Back to search

National and Kapodistrian University of Athens

Μελέτη της επίδρασης των στατινών στην ανίχνευση μικροεμβόλων στην οξεία φάση ισχαιμικού αγγειακού εγκεφαλικού επεισοδίου αθηροθρομβωτικής αιτιολογίας στην περιοχή κατανομής του καρωτιδικού συστήματος αγγείων

Abstract

dc:description

Atherosclerosis is a major cause of ischemic stroke that can be effectively prevented with appropriate lifestyle modifications and control of cardiovascular risk factors. Even though statin pretreatment (SP) is associated with better functional outcomes and lower risk of mortality in acute ischemic stroke, there are limited data evaluating this association in acute ischemic stroke (AIS) due to large artery atherosclerosis (LAA), which carries the highest risk of early stroke recurrence. There is also limited data on the underlying mechanism of this beneficial effect in terms of statin-induced reduction in artery-to-artery embolism and infarct volume as well as statin-induced improvement of collateral circulation. Methods1.Consecutive patients with acute LAA were prospectively evaluated from 7 tertiary-care stroke centers during a 3-year period. The outcome events of interest were neurologic improvement during hospitalization, favorable functional outcome (FFO), recurrent stroke, and death at 1 month. Statistical analyses were performed using univariable and multivariable Cox regression models adjusting for potential confounders. All analyses were repeated following propensity score matching.2.We prospectively evaluated consecutive patients with first-ever acute cerebral ischemia because of LAA in 3 tertiary stroke centers over a 2-year period. All patients underwent continuous 1-hour transcranial Doppler monitoring of the relevant intracranial vessel and microembolic signals (MES) were recorded. SP was recorded and dichotomized as high dose or low-to-moderate dose. 3.We performed a systematic review and meta-analysis of available observational studies reporting MES presence/absence or MES burden, categorized according to SP status, in patients with acute cerebral ischemia because of symptomatic (≥50%) LAA. We also performed a sensitivity analysis of studies with data on MES burden categorized according to SP status, and an additional subgroup analysis in patients receiving higher-dose SP.4.Consecutive LVO patients treated with mechanical thrombectomy in two centers in Greece were evaluated during a three-year period. Collateral status was assessed on digital subtraction angiography. Baseline characteristics, admission stroke severity and three-month functional outcome were recorded. The effect of statin pretreatment was compared to angiographic collaterals and clinical outcomes. 5.We performed a systematic review and meta-analysis to evaluate the association of SP with collateral circulation and final infarct volume (FIV) in AIS patients. We used a random-effects model for all the analyses, and pooled standardized mean differences and odds ratios on FIV and collateral status according to SP history, respectively.Results1.Statin pretreatment was documented in 192 of 516 consecutive patients with LAA. Statin pretreatment was associated with greater neurologic improvement during hospitalization and higher rates of 30-day FFO in unmatched and matched analyses. It was also related to lower risk of 1-month mortality and stroke recurrence in unmatched and matched analyses.2.SP was documented in 43 of 106 LAA patients. There was a significant dose-dependent effect between SP and MES prevalence. Similarly, a significant dose-dependent effect was documented between SP and MES burden. In multivariable logistic regression analysis adjusting for demographics, vascular risk factors, location of LAA, stroke severity, and other prevention therapies, SP was associated with lower likelihood of MES presence. In addition, SP was also independently related to higher odds of functional improvement.3.Seven eligible study protocols were identified (610 patients, 54% with SP). SP was associated with a reduced risk of MES detection during transcranial Doppler monitoring, with substantial heterogeneity between studies. In studies reporting MES burden (n=4), a significantly lower number of MES were identified in patients with compared with those without SP with no evidence of heterogeneity between studies. Subgroup analysis revealed that higher-dose SP further reduced the risk of detecting MES, with no evidence of heterogeneity between studies. 4.Patients with poor collaterals on DSA were more likely to harbor tandem occlusions and present with higher admission median NIHSS-scores. Patients with poor collaterals had higher median mRS-scores at discharge and at three-months. The three-month mortality and functional independence rates were higher and lower respectively in LVO patients with poor collaterals. Patients with SP showed a tendency for better collaterals that did not reach statistical significance. 5.We identified 9 eligible studies (1186 AIS patients). History of SP was associated with lower FIV compared to negative history of SP. A trend towards good collateral scores was observed in the SP group. Subgroup analysis demonstrated reduced FIV among atherosclerotic stroke patients with history of SP.ConclusionsStatin pretreatment in patients with acute LAA appears to be associated with better early outcomes regarding neurologic improvement, disability, survival, and stroke recurrence. SP in patients with acute LAA is related with reduced MES presence and lower MES burden with an apparent dose-dependent association. SP seems to be associated with a lower incidence and burden of MES in patients with acute cerebral ischemia due to underlying large artery atherosclerosis in a meta-analysis of observational studies. In patients with acute ischemic stroke due to large vessel occlusion treated with MT, statin pretreatment showed a non-significant trend for better collaterals. SP appears to be associated with decreased FIV, especially in atherosclerotic AIS, in a meta-analysis of available observational studies.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Safouris, Apostolos
  • Σαφούρης, Απόστολος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/46159

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Safouris, Apostolos; Σαφούρης, Απόστολος. Μελέτη της επίδρασης των στατινών στην ανίχνευση μικροεμβόλων στην οξεία φάση ισχαιμικού αγγειακού εγκεφαλικού επεισοδίου αθηροθρομβωτικής αιτιολογίας στην περιοχή κατανομής του καρωτιδικού συστήματος αγγείων. National and Kapodistrian University of Athens, 2019. http://hdl.handle.net/10442/hedi/46159